Valuation: Dr. Lal PathLabs Limited

Capitalization 244B 2.85B 2.44B 2.27B 2.11B 3.9B 4.33B 27.18B 10.39B 114B 10.68B 10.46B 420B P/E ratio 2026 *
48.7x
P/E ratio 2027 * 41.7x
Enterprise value 231B 2.69B 2.3B 2.14B 1.99B 3.68B 4.09B 25.68B 9.82B 108B 10.09B 9.88B 397B EV / Sales 2026 *
8.39x
EV / Sales 2027 * 7.37x
Free-Float
44.16%
Yield 2026 *
0.87%
Yield 2027 * 0.99%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.10%
1 week+6.16%
Current month+4.66%
1 month-1.14%
3 months+9.70%
6 months-0.06%
Current year-2.46%
More quotes
1 week 2,815
Extreme 2815
2,992
1 month 2,730
Extreme 2730
3,029.7
Current year 2,293.55
Extreme 2293.55
3,143.9
1 year 2,293.55
Extreme 2293.55
3,653.95
3 years 1,762.05
Extreme 1762.05
3,653.95
5 years 1,736.6
Extreme 1736.6
4,245.5
10 years 696.5
Extreme 696.5
4,245.5
More quotes
Manager TitleAgeSince
Chief Executive Officer - 2024-05-20
Director of Finance/CFO - 2018-08-09
Chief Operating Officer - 2022-03-31
Director TitleAgeSince
Chairman 75 2020-03-31
Director/Board Member 69 1995-02-13
Director/Board Member 64 2005-07-21
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.10%+6.16%-0.75%+34.36% 2.85B
-1.79%+1.10%+44.78%+326.79% 22.31B
+0.44%+1.38%+5.38%-18.26% 8.79B
-3.51%+0.40%-7.29%+217.39% 4.31B
-1.47%-.--% - - 3.26B
-5.01%-3.71%+141.26%+56.85% 2.48B
+0.96%+0.64%+2.98%-65.46% 1.81B
+2.23%+3.41%+20.33%-50.52% 1.26B
-3.37%-3.07%-19.21%-16.13% 1.25B
+0.13%-1.84%+31.79%+4.34% 1.22B
Average -1.15%+0.58%+24.36%+54.37% 4.96B
Weighted average by Cap. -1.38%-0.17%+30.44%+175.19%
See all sector performances

Financials

2026 *2027 *
Net sales 27.51B 321M 274M 255M 238M 439M 488M 3.06B 1.17B 12.88B 1.2B 1.18B 47.25B 30.8B 359M 307M 286M 266M 491M 546M 3.43B 1.31B 14.42B 1.35B 1.32B 52.89B
Net income 4.99B 58.13M 49.71M 46.3M 43.06M 79.57M 88.43M 555M 212M 2.34B 218M 214M 8.57B 5.83B 67.89M 58.05M 54.07M 50.29M 92.93M 103M 648M 248M 2.73B 255M 249M 10B
Net Debt -13.53B -158M -135M -126M -117M -216M -240M -1.5B -575M -6.33B -591M -579M -23.23B -17.34B -202M -173M -161M -150M -277M -307M -1.93B -738M -8.12B -758M -742M -29.79B
More financial data * Estimated data
Logo Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services in India. The Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its tests include Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, CBC Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Liver Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and Vitamin D Test. The Company has approximately 280 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore and Mumbai), 5,762 patient service centers (PSCs) and 11,619 pick-up points (PUPs). Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
Employees
4,980
More about the company
Date Price Change Volume
25-07-11 2,926.50 -0.10% 231,586
25-07-10 2,929.50 -1.15% 136,169
25-07-09 2,963.70 +2.91% 340,023
25-07-08 2,880.00 +0.89% 207,207
25-07-07 2,854.70 +0.20% 126,199

Delayed Quote NSE India S.E., July 11, 2025 at 07:49 am EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
25
Last Close Price
2,926.50INR
Average target price
3,078.24INR
Spread / Average Target
+5.19%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. LALPATHLAB Stock